<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pathogenesis of vasospasms following <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> and possible therapeutic efficacy of nimodipine (calcium channel blocking agent) are discussed </plain></SENT>
<SENT sid="1" pm="."><plain>The authors present their own experience in the treatment of 209 patients with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> with nimodipine </plain></SENT>
<SENT sid="2" pm="."><plain>Collected clinical results suggest the necessity of the combined treatment of vasospasm following <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> with nimodipine, <z:hpo ids='HP_0011105'>hypervolemia</z:hpo>, and hypertensive agents </plain></SENT>
</text></document>